Herman was doing academic research in the field of immunology for years. He then moved on to become Head R&D at IQ Products where he was responsible for setting up the successful spin-off IQ Therapeutics, a business which develops medicinal products by generating monoclonal antibodies from human plasma. Until 2012 he was the CSO at IQ Therapeutics,
after which he started working independently. Since 2021 Herman puts his knowledge and expertise into practice at Business Groningen. He is particularly interested in the interaction between the world of medical research and the business world and he uses this knowledge to support motivated researchers in marketing their research.